↓ Skip to main content

MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma

Overview of attention for article published in BMC Cancer, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

wikipedia
2 Wikipedia pages

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Published in
BMC Cancer, June 2012
DOI 10.1186/1471-2407-12-218
Pubmed ID
Authors

Daina Skiriute, Paulina Vaitkiene, Viktoras Saferis, Virginija Asmoniene, Kestutis Skauminas, Vytenis Pranas Deltuva, Arimantas Tamasauskas

Abstract

Methylation of promoter region is the major mechanism affecting gene expression in tumors. Recent methylome studies of brain tumors revealed a list of new epigenetically modified genes. Our aim was to study promoter methylation of newly identified epigenetically silenced genes together with already known epigenetic markers and evaluate its separate and concomitant role in glioblastoma genesis and patient outcome.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ukraine 1 2%
Brazil 1 2%
Unknown 44 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 22%
Student > Master 6 13%
Researcher 5 11%
Student > Bachelor 4 9%
Student > Postgraduate 4 9%
Other 9 20%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 16 35%
Biochemistry, Genetics and Molecular Biology 8 17%
Agricultural and Biological Sciences 5 11%
Neuroscience 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 2 4%
Unknown 10 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2019.
All research outputs
#7,452,489
of 22,783,848 outputs
Outputs from BMC Cancer
#2,060
of 8,289 outputs
Outputs of similar age
#55,178
of 167,042 outputs
Outputs of similar age from BMC Cancer
#16
of 70 outputs
Altmetric has tracked 22,783,848 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,289 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,042 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.